Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Bremelanotide is an MC4R-preferring agonist with reduced MC1R activity, which is why pigmentation effects are less pronounced in published bremelanotide work
Food and Drug Administration (2024) FDA drug shortages, U.S
Content:10 mg total per vial
PlexusDx serves all 50 states with medications compounded at licensed 503A pharmacies, making prescription-grade semaglutide accessible at $189/mo month-to-month, or from $149/mo on the 6-month plan
US$ 26.29
US$ 24.43
US$ 24.91
US$ 21.09
/product/27/748966/1.jpg?0336)
US$ 27.64
